Decode Age raises ₹14.48 crore to expand longevity products, labs and offline retail

Bengaluru-based Decode Age, which sells longevity supplements and gut-microbiome tests, will use its pre-Series A funding for new formulations, testing products, lab upgrades, research and offline expansion. It reported FY24 revenue of ₹11.9 crore, with supplements contributing about 93%.

— Source publishedTue, 28 Jul, 2026, 17:07 IST·First seen Tue, 28 Jul, 2026, 17:11 IST·Source YourStory

What happened

Bengaluru-based Decode Age sells longevity supplements and gut-microbiome tests, with supplements generating about 93% of revenue. After reporting FY24 revenue

Key facts

  • Founded in 2021; first products launched in November 2021
  • Initial founder investment: about ₹1 crore
  • Early funding: about $150,000
  • FY23 revenue: ₹3.07 crore
  • FY24 revenue: ₹11.9 crore
  • Supplements contribute roughly 93% of revenue
  • Reported supplement margins: close to 70%
  • Pre-Series A funding: ₹14.48 crore, announced December 2025

Why this matters

Decode Age’s move into formulations, microbiome testing, labs and physical retail makes it a potential partnership target for health retailers, diagnostic networks and wellness platforms seeking longevity capabilities.

What to watch

  • Share of revenue from diagnostics and test-to-supplement conversion rates.
  • Repeat purchase, subscription penetration and customer acquisition cost after offline expansion.
  • Number and quality of offline doors, clinic/lab partnerships and whether stores are owned, franchised or distribution-led.
  • Lab capacity, test turnaround time and evidence supporting personalized recommendations.
  • Gross-margin movement as retail, distribution and diagnostic fulfillment scale.
  • Regulatory developments around nutraceutical claims, diagnostic interpretation and personalized health recommendations.
  • Whether larger wellness, pharmacy, diagnostics or consumer-health players launch comparable test-plus-supplement offerings.
  • Launch bundled longevity programs combining test kits, consultations or personalized protocols with subscription supplement replenishment.
  • Expand through premium pharmacy, wellness-clinic, gym, preventive-health and modern-trade partnerships before committing to a large owned-store network.
  • Use lab upgrades to reduce test turnaround time, improve report personalization and build proprietary longitudinal health-data assets.
  • Add science-led formulations targeting metabolic health, gut health, sleep, women’s health and healthy ageing, while strengthening clinical-validation and claims substantiation.
  • Build offline sampling, assisted selling and membership models to convert retail discovery into D2C replenishment revenue.

Also reported by